188 related articles for article (PubMed ID: 19369417)
21. Uncoupling effects of estrogen receptor α on LKB1/AMPK interaction upon adiponectin exposure in breast cancer.
Mauro L; Naimo GD; Gelsomino L; Malivindi R; Bruno L; Pellegrino M; Tarallo R; Memoli D; Weisz A; Panno ML; Andò S
FASEB J; 2018 Aug; 32(8):4343-4355. PubMed ID: 29513571
[TBL] [Abstract][Full Text] [Related]
22. A kinetic model identifies phosphorylated estrogen receptor-α (ERα) as a critical regulator of ERα dynamics in breast cancer.
Tian D; Solodin NM; Rajbhandari P; Bjorklund K; Alarid ET; Kreeger PK
FASEB J; 2015 May; 29(5):2022-31. PubMed ID: 25648997
[TBL] [Abstract][Full Text] [Related]
23. Kruppel-like factor 9 is a negative regulator of ligand-dependent estrogen receptor alpha signaling in Ishikawa endometrial adenocarcinoma cells.
Velarde MC; Zeng Z; McQuown JR; Simmen FA; Simmen RC
Mol Endocrinol; 2007 Dec; 21(12):2988-3001. PubMed ID: 17717078
[TBL] [Abstract][Full Text] [Related]
24. Proteasome inhibition represses ERalpha gene expression in ER+ cells: a new link between proteasome activity and estrogen signaling in breast cancer.
Powers GL; Ellison-Zelski SJ; Casa AJ; Lee AV; Alarid ET
Oncogene; 2010 Mar; 29(10):1509-18. PubMed ID: 19946334
[TBL] [Abstract][Full Text] [Related]
25. PKA-mediated stabilization of FoxH1 negatively regulates ERalpha activity.
Yum J; Jeong HM; Kim S; Seo JW; Han Y; Lee KY; Yeo CY
Mol Cells; 2009 Jul; 28(1):67-71. PubMed ID: 19711044
[TBL] [Abstract][Full Text] [Related]
26. Endocrine therapy resistance can be associated with high estrogen receptor alpha (ERalpha) expression and reduced ERalpha phosphorylation in breast cancer models.
Kuske B; Naughton C; Moore K; Macleod KG; Miller WR; Clarke R; Langdon SP; Cameron DA
Endocr Relat Cancer; 2006 Dec; 13(4):1121-33. PubMed ID: 17158758
[TBL] [Abstract][Full Text] [Related]
27. Wnt signaling may be activated in a subset of Peutz-Jeghers syndrome polyps closely correlating to LKB1 expression.
Ma Y; Zhang G; Fu X; Xia O; Zhan C; Li L; Wang Z; Wu B
Oncol Rep; 2010 Jun; 23(6):1569-76. PubMed ID: 20428811
[TBL] [Abstract][Full Text] [Related]
28. Tumor suppressor LKB1 inhibits activation of signal transducer and activator of transcription 3 (STAT3) by thyroid oncogenic tyrosine kinase rearranged in transformation (RET)/papillary thyroid carcinoma (PTC).
Kim DW; Chung HK; Park KC; Hwang JH; Jo YS; Chung J; Kalvakolanu DV; Resta N; Shong M
Mol Endocrinol; 2007 Dec; 21(12):3039-49. PubMed ID: 17761947
[TBL] [Abstract][Full Text] [Related]
29. LKB1 interacts with and phosphorylates PTEN: a functional link between two proteins involved in cancer predisposing syndromes.
Mehenni H; Lin-Marq N; Buchet-Poyau K; Reymond A; Collart MA; Picard D; Antonarakis SE
Hum Mol Genet; 2005 Aug; 14(15):2209-19. PubMed ID: 15987703
[TBL] [Abstract][Full Text] [Related]
30. Vascular endothelial growth factor receptor-2 expression is down-regulated by 17beta-estradiol in MCF-7 breast cancer cells by estrogen receptor alpha/Sp proteins.
Higgins KJ; Liu S; Abdelrahim M; Vanderlaag K; Liu X; Porter W; Metz R; Safe S
Mol Endocrinol; 2008 Feb; 22(2):388-402. PubMed ID: 18006642
[TBL] [Abstract][Full Text] [Related]
31. Expression of estrogen receptor alpha, retinoic acid receptor alpha and cellular retinoic acid binding protein II genes is coordinately regulated in human breast cancer cells.
Lu M; Mira-y-Lopez R; Nakajo S; Nakaya K; Jing Y
Oncogene; 2005 Jun; 24(27):4362-9. PubMed ID: 15870697
[TBL] [Abstract][Full Text] [Related]
32. Toll-like receptor 9 agonist inhibits ERalpha-mediated transactivation by activating NF-kappaB in breast cancer cell lines.
Qiu J; Wang X; Guo X; Zhao C; Wu X; Zhang Y
Oncol Rep; 2009 Oct; 22(4):935-41. PubMed ID: 19724876
[TBL] [Abstract][Full Text] [Related]
33. KLF4 suppresses estrogen-dependent breast cancer growth by inhibiting the transcriptional activity of ERalpha.
Akaogi K; Nakajima Y; Ito I; Kawasaki S; Oie SH; Murayama A; Kimura K; Yanagisawa J
Oncogene; 2009 Aug; 28(32):2894-902. PubMed ID: 19503094
[TBL] [Abstract][Full Text] [Related]
34. The LIM protein Ajuba recruits DBC1 and CBP/p300 to acetylate ERα and enhances ERα target gene expression in breast cancer cells.
Xu B; Li Q; Chen N; Zhu C; Meng Q; Ayyanathan K; Qian W; Jia H; Wang J; Ni P; Hou Z
Nucleic Acids Res; 2019 Mar; 47(5):2322-2335. PubMed ID: 30597111
[TBL] [Abstract][Full Text] [Related]
35. Novel estrogen receptor-alpha binding sites and estradiol target genes identified by chromatin immunoprecipitation cloning in breast cancer.
Lin Z; Reierstad S; Huang CC; Bulun SE
Cancer Res; 2007 May; 67(10):5017-24. PubMed ID: 17510434
[TBL] [Abstract][Full Text] [Related]
36. An Hsp27-related, dominant-negative-acting intracellular estradiol-binding protein.
Chen H; Hewison M; Hu B; Sharma M; Sun Z; Adams JS
J Biol Chem; 2004 Jul; 279(29):29944-51. PubMed ID: 15123601
[TBL] [Abstract][Full Text] [Related]
37. The estrogen receptor-interacting protein HPIP increases estrogen-responsive gene expression through activation of MAPK and AKT.
Wang X; Yang Z; Zhang H; Ding L; Li X; Zhu C; Zheng Y; Ye Q
Biochim Biophys Acta; 2008 Jun; 1783(6):1220-8. PubMed ID: 18302941
[TBL] [Abstract][Full Text] [Related]
38. Differential regulation of native estrogen receptor-regulatory elements by estradiol, tamoxifen, and raloxifene.
Levy N; Tatomer D; Herber CB; Zhao X; Tang H; Sargeant T; Ball LJ; Summers J; Speed TP; Leitman DC
Mol Endocrinol; 2008 Feb; 22(2):287-303. PubMed ID: 17962382
[TBL] [Abstract][Full Text] [Related]
39. LKB1 deletion with the RIP2.Cre transgene modifies pancreatic beta-cell morphology and enhances insulin secretion in vivo.
Sun G; Tarasov AI; McGinty JA; French PM; McDonald A; Leclerc I; Rutter GA
Am J Physiol Endocrinol Metab; 2010 Jun; 298(6):E1261-73. PubMed ID: 20354156
[TBL] [Abstract][Full Text] [Related]
40. Functional analysis of Peutz-Jeghers mutations reveals that the LKB1 C-terminal region exerts a crucial role in regulating both the AMPK pathway and the cell polarity.
Forcet C; Etienne-Manneville S; Gaude H; Fournier L; Debilly S; Salmi M; Baas A; Olschwang S; Clevers H; Billaud M
Hum Mol Genet; 2005 May; 14(10):1283-92. PubMed ID: 15800014
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
